0001524547-19-000009.txt : 20190116 0001524547-19-000009.hdr.sgml : 20190116 20190116162227 ACCESSION NUMBER: 0001524547-19-000009 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190114 FILED AS OF DATE: 20190116 DATE AS OF CHANGE: 20190116 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talamo Joseph CENTRAL INDEX KEY: 0001524547 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 19529277 MAIL ADDRESS: STREET 1: CALADRIUS BIOSCIENCES, INC. STREET 2: 800 WESTCHESTER AVENUE. STE N341 CITY: RYE BROOK STATE: NY ZIP: 10573 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-842-0100 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 FORMER COMPANY: FORMER CONFORMED NAME: PHASE III MEDICAL INC/DE DATE OF NAME CHANGE: 20030819 4 1 wf-form4_154767373106213.xml FORM 4 X0306 4 2019-01-14 0 0000320017 CALADRIUS BIOSCIENCES, INC. CLBS 0001524547 Talamo Joseph C/O CALADRIUS BIOSCIENCES, INC. 110 ALLEN ROAD, 2ND FLOOR BASKING RIDGE NJ 07920 0 1 0 0 SVP and CFO Common Stock 2019-01-14 4 A 0 16000 0 A 49415 D Common Stock 2019-01-14 4 F 0 2159 0 D 47256 D Stock Options (Right to Buy) 4.95 2019-01-14 4 A 0 24000 0 A 2019-01-14 2029-01-14 Common Stock 24000.0 24000 D Represents 16,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. Includes 18,650 unvested restricted stock awards. One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. Joseph Talamo, by: /s/Todd C. Girolamo, Esq., Attorney-in-Fact 2019-01-16